[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-centessa-pharmaceuticals-plc-n330194d846-4046-7d60-9ca7-4fc6115b905e":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":21,"enrichStatus":19,"triageKind":18,"triageImportance":18,"expandEligible":18,"summarizeEligible":18,"eventEligible":18,"eventType":18,"eventAction":18},"centessa-pharmaceuticals-plc-n330194d846-4046-7d60-9ca7-4fc6115b905e","1738794920000","Centessa Pharmaceuticals plc (NASDAQ:CNTA) CTO Sells $185,460.00 in Stock","Centessa Pharmaceuticals plc (NASDAQ:CNTA - Get Free Report) CTO Tia L. Bush sold 11,000 shares of Centessa Pharmaceuticals stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $16.86, for a total transaction of $185,460.00. Following the sale, the chief technology officer now owns 121,503 shares of the company's stock, valued at approximately $2,048,540.58. This represents a 8.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.","https://www.marketbeat.com/instant-alerts/centessa-pharmaceuticals-plc-nasdaqcnta-cto-sells-18546000-in-stock-2025-02-04/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"-\"]","[{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN"]